About Us

Medispace Innovations Private Limited is a biotechnology company dedicated to advancing sustainable marine biorefinery and circular bioeconomy solutions through the valorization of seafood processing by-products. Established in 2025, the company focuses on transforming shrimp shell waste and other marine biomass into high-value bio-based products that support resource efficiency, environmental sustainability, and industrial innovation.

Leveraging innovative chemo-enzymatic and bioconversion technologies, Medispace develops and manufactures specialty biomaterials and bioactive ingredients including chitin, chitosan, glucosamine hydrochloride, protein hydrolysates, fermentation feedstocks, biofertilizers, biostimulants, industrial enzymes, and other marine-derived biomolecules. Our integrated processing approach enables the conversion of underutilized marine resources into commercially valuable products for diverse sectors such as agriculture, aquaculture, biotechnology, healthcare, food processing, environmental management, and industrial manufacturing.

The company actively engages in research, product development, and process scale-up activities in collaboration with leading scientific institutions and research organizations. Through continuous innovation, Medispace seeks to develop scalable and environmentally responsible technologies that reduce waste, recover valuable resources, and create sustainable alternatives to conventional materials.

Guided by the principles of the Blue Economy, we are committed to promoting sustainable industrial development, supporting responsible resource utilization, and contributing to a circular and resource-efficient future. Our mission is to create value from marine biomass while delivering innovative solutions that benefit industry, society, and the environment.